FOS and hepatocellular carcinoma: In addition to this notion, complementary evidence to support JNK1 activation in a subset of HCC tissue was previously provided by Lee et al.[22] who demonstrated a strong enrichment of the AP-1 signaling, a direct down-stream target of JNK1, in HB-type HCC samples.